INBRAIN Neuroelectronics can handle well one of the graphical basic principles of human computer-computer systems

– First Operation am Menschen im Salford Royal Hospital in Manchester, Great Britain

BARCELONA, Spain, September 26, 2024–(BUSINESS WIRE)–INBRAIN Neuroelectronics, a company for computer-assisted cut-up therapy (BCI-Tx), is a pioneer in the field of graphical basal neuronal technology, which has performed the first operation with short-term Cut-up at a patient can take into account that a tumor resection is not possible. The BCI technology of the INBRAIN war in the Low, with micrometer-genauer examinations will be carried out and gekrebsartigem Hirngewebe will not be separated.

Die Meilenstein has a strong reinforcement of the graphic basis of the BCI technology on the Entschlüsselung and transposition of gehirnsignals which demonstrate and his own work for the Einsatz in the Precision surgery in Illnesses wie Krebs and in der Neurotechnologie in the sequel Sin was missed. The research at the University of Manchester is sponsored and continued by the Graphene Flagship Project of the European Commission which has received funding.

The clinical trial is being conducted at Salford Royal Hospital, part of the Northern Care Alliance NHS Foundation Trust in Manchester, UK. The study is led by clinical research lead Dr David Coope, a neurosurgeon at the Manchester Centre for Clinical Neuroscience and head of the Brain Tumor Unit at the Geoffrey Jefferson Brain Research Centre, and lead scientific researcher Dr Kostas Kostarelos, Professor of Nanomedicine at the University of Manchester, the Catalan Institute of Nanoscience & Nanotechnology and founder of INBRAIN.

“The world was the first graph-based BCI technology to undermine the transformative effect of graph-based neuronal technology in medicine. This clinical breakthrough is a new way for BCI technology and the path for neuronal development as a treatment as a therapeutic intervention,” says Carolina Aguilar, CEO and co-founder of INBRAIN Neuroelectronics.

INBRAIN’s BCI platform now has the extended properties of graphene, a material that is a solitary sliver of the best quality. Obwohl is one of the best ways to use material of the Wissenschaft trade, it is the tombstone used as steel and a unique combination of electronic and mechanical properties, which is ideal for neurotechnological innovations.

“We inherited the ability to achieve vitality in the sense that we have to fight with signal trust in our own metals and materials. Graphene is extremely close to the treatment and stimulation, which makes the duration of the treatment higher than the function of the patient, such as movement, language or cognition, of separating meaning,” says Dr. David Coope, of the neurosurgeon, of the Eingriff who has worked through time.

“After technical research and research has been done on the first study of INBRAIN in humans of 8 to 10 patients, in first line, it is so that the Sicherheit of Graphen directly contacts the people who demonstrate,” says Dr. Kostas Kostarelos, Mitbegründer von INBRAIN Neuroelectronics. “The research on the overarching knowledge of graphen has provided other materials in the development of the functional operation in watch and Sleeping state demonstrations.”

“The integration of graphene and AI with progressive half-wave technology has enabled INBRAIN, a new generation of minimally invasive BCI therapy for the integration, which allows for the personalized neurological treatment of neurological disorders,” says Dr. Jose A. Garrido, founder and scientific leader of INBRAIN and ICREA professor at the Katalanische Institut für Nanoscience and Nanotechnology.

Professor Dr. Sir Kostya Novoselov, Nobel Prize winner and Member of the Vision Board of INBRAIN, in 2004 at the University of Manchester stabilized the first graphene isolation and now at the National University of Singapore, said: ‘It is a matter of seeing whoever has Peculiarities of Graphen new Frontiers in Medical Technology erschließen. During the period that the ergebnis has been in the Frames of the Graphen Flagship programs for a long time, we can now start to transform the results of the transformation.’

INBRAIN’s Graphene-based Intelligent Network Decoding & Modulation (BCI-Tx) platform research has provided the U.S. Food & Drug Administration (FDA) with a breakthrough device for Parkinson’s disease. INBRAIN’s BCI-Tx platform has utilized the unique graphene properties, ultra-high signal transmission, and adaptive neuroelectronic therapy with a true biomarker and price modulation short and subshort structure in the micrometer for the novel neuronal network zwerke ermöglicht.

Laut Carolina Aguilar is an INBRAIN researcher in neurological neurology and the integration of BCI decoding with high-quality neuromodulation, a number of functions and symptoms of lindern. Because it is a continuous, personalized management, it is worth maximizing and taking the time to minimize.”

Über INBRAIN Neuroelectronics

INBRAIN Neuroelectronics leads the world of the graphical-based Brain-Computer-Interface (BCI) therapy platform as a pioneer in real precision neurology. A combined technology offers BCI decotherapy with micrometric modulation, an adaptive, personalizable treatment for Parkinson’s disease, epilepsy and disease recovery. During the continuous use of real therapies and autonomous therapies, the AI-enhanced platform for therapeutic therapies is maximized and treatment is minimized. During the strategic cooperation, among others with Merck KGAa and our subsidiary INNERVIA Bioelectronics, there are innovative solutions for peripheral nerve and systemic development and development of the possibilities of neurotechnology and bioelectronics. Further information can be found at www.inbrain-neuroelectronics.com and follow us on LinkedIn.

About Northern Healthcare Alliance (NCA)

Northern Care Alliance NHS Foundation Trust provides inpatient and outpatient healthcare services in Salford, Oldham, Bury and Rochdale. The dedicated team of 20,000 has benefited a million people in the greater Manchester area and has achieved a very high level of achievement and renewed Leistungen en Arbeitt gemeinsam, Leben zu retten and zu verbessern. For more information about the NCA, visit www.northerncarealliance.nhs.uk

About the University of Manchester

The University of Manchester is good for its rapid development, its renewed study and its learning process for its commitment to social responsibility. The Einrichtung der Russell Group is the best university in Great Britain and is ranked 38th (Academic Ranking of World Universities). The Gemeinschaft der Wahrhaft Internationalen Universität has more than 44,000 students, 12,000 students and 500,000 alumni from 190 Ländern. Gemeinsam presents itself as the great herausforderungen of the world – the social and ecological effect of the University is ranked among the Top Ten in well-being ( Higher Education Impact rankings). The university is a kraftwerk of Forschung and Entdeckung; 25 Nobel laureates for their former work and students; and you can use the Research Power Ranking – the quality and quality of research and research – the Research Excellence Framework (REF) 2021 from the British Regie op de Fünften Platz. Die Einrichtung ist die beliebteste in Großbritannien für Bewerbungen von Bachelor-Studierenden (UCAS-Zyklus 2021) and also die beliebteste Universität bei den führenden Arbeitgebern Großbritanniens (The Graduate Market, 2023).

The general text, in the original text that is light, is the official and authorized version. The settings must be adjusted. Only the Sprachversion, the original veröffentlichte wurde, is legally valid. Use the original version of the display ab.

Original version on businesswire.com as follows: https://www.businesswire.com/news/home/20240926403414/de/

Contacts

Media contact
Kimberly Ha
KKH Advisors
917-291-5744
[email protected]